Bayer CropScience Ltd, a key division of Bayer AG, specializes in crop protection, seeds, and non-agricultural pest control, offering advanced herbicides, fungicides, insecticides, and seed treatments to enhance crop health. With cutting-edge genetics and traits, its high-quality seeds improve yields and withstand environmental challenges, supporting modern agriculture. Committed to sustainability and regenerative farming, Bayer invests in research and development across biotechnology, crop science, and digital farming technologies to drive innovation. The company also aids farmers through food chain partnerships, helplines, and programs to boost productivity and profitability. Additionally, its environmental science division addresses public health and ornamental pest control needs, integrating innovation with sustainability to tackle global food security challenges while promoting responsible practices.
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | |
| Promoters + | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% |
| FIIs + | 3.53% | 3.62% | 3.63% | 3.30% | 3.42% |
| DIIs + | 12.70% | 12.80% | 12.47% | 12.08% | 11.69% |
| Public + | 12.33% | 12.15% | 12.47% | 13.18% | 13.45% |
| No. of Shareholders | 46,907 | 45,852 | 46,201 | 51,289 | 54,289 |
The shareholding pattern of Bayer CropScience showcases a stable ownership structure, with promoters consistently holding a dominant 71.44% stake throughout December 2023 to December 2024. Foreign Institutional Investors (FIIs) maintained a slight fluctuation in their holdings, increasing from 3.53% in December 2023 to 3.62% in March 2024, peaking at 3.63% in June 2024, and later settling at 3.42% by December 2024. Domestic Institutional Investors (DIIs) exhibited a gradual decline, starting at 12.70% in December 2023 and decreasing steadily to 11.69% by December 2024. Conversely, public shareholding saw a rising trend, growing from 12.33% in December 2023 to 13.45% in December 2024, reflecting increased retail investor participation. The total number of shareholders for Bayer CropScience also increased significantly, from 46,907 in December 2023 to 54,289 by December 2024, indicating growing investor interest in the company.
Below are the trading platforms that you can use to purchase Bayer CropScience shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
| When | Maximum Price | Minimum Price |
| March 2025 | 4,949.77 | 3,807.51 |
| April 2025 | 4,900.76 | 3,769.82 |
| May 2025 | 4,758.02 | 3,660.02 |
| June 2025 | 4,972.13 | 3,824.72 |
| July 2025 | 4,874.64 | 3,749.72 |
| August 2025 | 5,025.40 | 3,865.69 |
| September 2025 | 5,085.71 | 3,912.08 |
| October 2025 | 5,217.93 | 4,013.80 |
| November 2025 | 5,348.38 | 4,114.14 |
| December 2025 | 5,589.06 | 4,299.28 |
As we step into 2025, the share price of Bayer CropScience is expected to exhibit a dynamic trend throughout the year. In March 2025, the share price is projected to reach a maximum of ₹4,949.77 and a minimum of ₹3,807.51. By December 2025, the share price is anticipated to climb further, with a maximum of ₹5,589.06 and a minimum of ₹4,299.28, reflecting strong growth potential.
| When | Maximum Price | Minimum Price |
| January 2026 | 5,756.73 | 4,428.25 |
| February 2026 | 5,612.81 | 4,317.55 |
| March 2026 | 5,725.07 | 4,403.90 |
| April 2026 | 5,841.91 | 4,493.78 |
| May 2026 | 5,784.07 | 4,449.28 |
| June 2026 | 5,928.67 | 4,560.51 |
| July 2026 | 5,812.42 | 4,471.09 |
| August 2026 | 5,992.19 | 4,609.37 |
| September 2026 | 6,112.03 | 4,701.56 |
| October 2026 | 6,270.94 | 4,823.80 |
| November 2026 | 6,427.72 | 4,944.40 |
| December 2026 | 6,588.41 | 5,068.01 |
As we move into 2026, the share price of Bayer CropScience is expected to reflect steady growth and strong market interest throughout the year. In January 2026, the share price is projected to reach a maximum of ₹5,756.73 and a minimum of ₹4,428.25. By December 2026, the share price is anticipated to rise further, with a maximum of ₹6,588.41 and a minimum of ₹5,068.01.
| When | Maximum Price | Minimum Price |
| January 2027 | 6,654.29 | 5,118.69 |
| February 2027 | 6,824.92 | 5,249.94 |
| March 2027 | 7,091.09 | 5,454.68 |
| April 2027 | 6,952.05 | 5,347.73 |
| May 2027 | 6,749.56 | 5,191.97 |
| June 2027 | 7,053.29 | 5,425.61 |
| July 2027 | 6,914.99 | 5,319.22 |
| August 2027 | 7,128.86 | 5,483.74 |
| September 2027 | 7,378.37 | 5,675.67 |
| October 2027 | 7,570.20 | 5,823.23 |
| November 2027 | 7,759.46 | 5,968.81 |
| December 2027 | 7,953.44 | 6,118.03 |
| When | Maximum Price | Minimum Price |
| January 2028 | 8,112.51 | 6,240.40 |
| February 2028 | 8,320.53 | 6,400.41 |
| March 2028 | 8,645.03 | 6,650.02 |
| April 2028 | 8,475.52 | 6,519.63 |
| May 2028 | 8,228.66 | 6,329.74 |
| June 2028 | 8,598.95 | 6,614.57 |
| July 2028 | 8,430.34 | 6,484.88 |
| August 2028 | 8,691.07 | 6,685.44 |
| September 2028 | 8,995.26 | 6,919.43 |
| October 2028 | 9,229.14 | 7,099.34 |
| November 2028 | 9,459.86 | 7,276.82 |
| December 2028 | 9,696.36 | 7,458.74 |
| When | Maximum Price | Minimum Price |
| January 2029 | 9,890.29 | 7,607.91 |
| February 2029 | 10,143.89 | 7,802.99 |
| March 2029 | 10,539.50 | 8,107.31 |
| April 2029 | 10,332.84 | 7,948.34 |
| May 2029 | 10,031.88 | 7,716.83 |
| June 2029 | 10,483.32 | 8,064.09 |
| July 2029 | 10,277.76 | 7,905.97 |
| August 2029 | 10,595.63 | 8,150.49 |
| September 2029 | 10,966.48 | 8,435.75 |
| October 2029 | 11,251.61 | 8,655.08 |
| November 2029 | 11,532.90 | 8,871.46 |
| December 2029 | 11,821.22 | 9,093.25 |
| When | Maximum Price | Minimum Price |
| January 2030 | 12,057.65 | 9,275.11 |
| February 2030 | 12,366.82 | 9,512.94 |
| March 2030 | 12,849.12 | 9,883.94 |
| April 2030 | 12,597.18 | 9,690.14 |
| May 2030 | 12,230.27 | 9,407.90 |
| June 2030 | 12,780.63 | 9,831.26 |
| July 2030 | 12,530.03 | 9,638.49 |
| August 2030 | 12,917.56 | 9,936.58 |
| September 2030 | 13,369.67 | 10,284.36 |
| October 2030 | 13,717.28 | 10,551.76 |
| November 2030 | 14,060.22 | 10,815.55 |
| December 2030 | 14,411.72 | 11,085.94 |
As we progress into 2030, the share price of Bayer CropScience is expected to demonstrate significant growth, reflecting strong market performance. In January 2030, the share price is projected to reach a maximum of ₹12,057.65 and a minimum of ₹9,275.11. By December 2030, the share price is anticipated to climb further, with a maximum of ₹14,411.72 and a minimum of ₹11,085.94.
Financial Condition of Bayer CropScience
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
| Sales + | 3,609 | 4,261 | 4,734 | 5,140 | 5,103 | 5,217 |
| Expenses + | 2,883 | 3,450 | 3,923 | 4,216 | 4,147 | 4,603 |
| Operating Profit | 726 | 812 | 812 | 924 | 956 | 614 |
| OPM % | 20% | 19% | 17% | 18% | 19% | 12% |
| Other Income + | -64 | 69 | 112 | 168 | 79 | 114 |
| Interest | 14 | 13 | 13 | 22 | 20 | 16 |
| Depreciation | 65 | 74 | 64 | 80 | 74 | 66 |
| Profit before tax | 583 | 794 | 847 | 990 | 941 | 645 |
| Tax % | 19% | 38% | 24% | 23% | 21% | |
| Net Profit + | 474 | 493 | 645 | 758 | 740 | 521 |
| EPS in Rs | 105.58 | 109.72 | 143.58 | 168.71 | 164.77 | 115.86 |
| Dividend Payout % | 24% | 105% | 104% | 77% | 85% |
The financial performance of Bayer CropScience over the years reflects a consistent growth trajectory in sales and profitability, despite fluctuations in certain metrics. From March 2020 to March 2024, the company’s sales steadily increased from ₹3,609 crore to ₹5,103 crore, with the trailing twelve months (TTM) reaching ₹5,217 crore. Operating profit showed resilience, rising from ₹726 crore in March 2020 to ₹956 crore in March 2024, although the TTM figure dipped to ₹614 crore due to increased expenses. The Operating Profit Margin (OPM) remained within the range of 17% to 20% over the years but declined to 12% in the TTM period.
Other income demonstrated variability, peaking at ₹168 crore in March 2023 but stabilizing at ₹114 crore in the TTM period. Profit before tax improved significantly, from ₹583 crore in March 2020 to ₹990 crore in March 2023, before moderating to ₹645 crore in the TTM. Net profit grew from ₹474 crore in March 2020 to ₹758 crore in March 2023, settling at ₹521 crore in the TTM period. The company’s Earnings Per Share (EPS) followed a similar trend, increasing from ₹105.58 in March 2020 to ₹168.71 in March 2023, with the TTM figure at ₹115.86. Dividend payout percentages have fluctuated, ranging from 24% to 105%, reflecting varying distribution policies over the years. Bayer CropScience’s financials underscore its focus on maintaining steady growth while adapting to market dynamics.
FAQs
What is Bayer CropScience’s current market capitalization?
Bayer CropScience’s current market capitalization stands at ₹21,350 Cr.
The share price target for 2025 ranges from ₹5,589.06 (maximum) to ₹3,660.02 (minimum) respectively.
The share price target for 2030 ranges from ₹14,411.72 (maximum) to ₹9,275.11 (minimum).
What is Bayer CropScience’s current Price/Earnings (PE) ratio?
The stock’s Price/Earnings (PE) ratio is currently 41.0.
What is the face value of Bayer CropScience’s stock?
The face value of Bayer CropScience’s stock is ₹10.0.
Also Read
- SKF India Share Price Target 2025, 2026 to 2030
- Apollo Micro Systems Share Price Target 2025, 2026 to 2030
- Godawari Power & Ispat Share Price Target 2025, 2026 to 2030
Bayer CropScience stands out as a leader in agriculture innovation, leveraging cutting-edge technologies and sustainable practices to address global food security challenges. The company’s robust financial performance, reflected in consistent growth in sales and profitability from 2020 to 2024, highlights its market resilience and operational efficiency. Furthermore, the stable shareholding pattern and increasing retail investor participation underscore growing confidence in Bayer CropScience’s long-term growth potential. With a projected share price trajectory indicating significant growth through 2025 to 2030, the company is poised to deliver value to investors while continuing its commitment to advancing modern agriculture.
What did we learn?
